Sebastian Himbert and Maikel Rheinstadter are part of an interdisciplinary team at McMaster researching the use of red blood cells to transport viral agents.
(Photo by Georgia Kirkos/McMaster University)
Physicists, chemists and immunologists at McMaster University have teamed up to modify red blood cells to transport viral agents which can safely trigger the immune system to protect the body against SARS-CoV-2, creating a promising new vehicle for vaccine delivery.
Developing new strategies and vaccine technologies is critical for controlling the pandemic and preparing for future outbreaks as the coronavirus continues to evolve and mutate, say the researchers.
The new method, described in the journal PLOS ONE is an entirely unique approach to vaccination. Red blood-cell membranes are embedded with SARS-CoV-2 spike proteins, which then form virus-like particles.
“We take red blood cells and remove everything from the inside. We then attach spike proteins to their outside to mimic a coronavirus,” explains graduate student Isabella Passos-Gastaldo, a lead author on the paper.
The particles, shown to activate the immune system and produce antibodies in mice, are completely harmless.
“Current vaccine delivery methods often cause drastic immune system reactions and have short-lived responses,” says Maikel Rheinstadter, a senior supervisor on the paper and a professor in the Department of Physics & Astronomy at McMaster.
“Some of the vaccines that have been developed have shown side effects. This delivery platform opens new possibilities for vaccines and therapeutics.”
The researchers found cells can be loaded with a large dose of viral proteins, yet likely produce few side effects, making the new method more tolerable and effective than other vaccine options.
“We have developed a method where we can trigger an immune response without the use of genetic material and yet we are able to synthesize these particles in a very short amount of time,” says Sebastian Himbert, lead author on the study and a recent graduate student in the Department of Physics & Astronomy at McMaster.
The technology can be quickly adapted to develop vaccines for variants or new viruses that may emerge in future.
“This is the kind of creative, interdisciplinary research that McMaster is known for. It was exhilarating working with physicists, structural biologists and immunologists to design a radically different vaccine platform,” says Dawn Bowdish, Professor of Medicine at McMaster and Canada Research Chair in Aging & Immunity and co-author of the paper.
The researchers first reported this technique in 2020, when they modified red blood cells to deliver drugs throughout the body, which could then target infections or treat catastrophic diseases such as cancer or Alzheimer’s.
“This platform makes our own blood cells smart in many different ways,” explains Rheinstadter. In this case it’s a vaccine.”
“We are using our own cells much like nano robots inside of our bodies and whenever they see a disease, they can fight it.”
More from: McMaster University
The Latest on: Vaccine delivery method
- FDA allows new delivery of monkeypox vaccine to make more doses availableon August 9, 2022 at 3:40 pm
Monkeypox vaccine shots will soon be delivered differently and in a way that allows 5 doses to be obtained from a current single dose. The Food and Drug Administration Tuesday issued an emergency use ...
- Biden administration authorizes emergency monkeypox vaccine strategyon August 9, 2022 at 2:54 pm
Giving shots between the skin, instead of under it, will stretch a limited supply, but there's little data to support its efficacy.
- New monkeypox vaccine strategy underway to increase availabilityon August 9, 2022 at 12:50 pm
The Biden administration is moving forward with a plan to increase the U.S. monkeypox vaccine supply by as much as five times. In an announcement Tuesday, Health and Human Services Secretary Xavier ...
- Will low-dose vaccination stretch the monkeypox vaccine supply, or backfire?on August 9, 2022 at 6:21 am
A hasty decision to try an unproven and risky strategy to stretch the existing monkeypox vaccine supply may interfere with developing a national plan to quell this outbreak.
- Officials Investigate if They Can Stretch Single Monkeypox Vaccine Dose into 5 Doseson August 8, 2022 at 1:22 pm
The Biden administration is considering recommending a change in how health care workers give the monkeypox vaccine, so it can stretch its limited supplies, US Food and Drug Administration (FDA) ...
- Change in monkeypox vaccine injection method could mean more doses but may not be easy, expert - 1bron August 4, 2022 at 9:27 pm
As part of the Biden administration's declaration of the monkeypox outbreak in the US as a public health emergency, it's looking into administering Jynneos vaccine shots intradermally instead of ...
- Scientists compare skin patch vs. needle vaccine against SARS-CoV-2 variantson August 1, 2022 at 7:09 pm
Share on Pinterest A recent animal study shows that administering a genetically modified form of the SARS-CoV-2 spike protein using a skin patch produced a potent neutralizing antibody response ...
- This needle-free COVID vaccine fights Omicron, Delta better. Know how to use the jabon August 1, 2022 at 4:01 pm
The Hexapro COVID vaccine was tested using the Vaxxas high-density microarray patch (HD-MAP) technology, and the results showed that the patch is far more effective at neutralising COVID-19 variants.
- Needle-free COVID Vaccine Patch Could Replace Painful Injectionon July 29, 2022 at 5:12 am
Forget those painful injections. Needle-free COVID vaccine patch could be the best alternative to a traditional needle vaccine in the fight against COVID-19 variants like Omicron.
- COVID vaccine patch fights variants better than needleson July 28, 2022 at 12:28 am
A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice.
via Bing News
The Latest on: Vaccine delivery method
via Google News